Manfred Ruediger is the founder of Ariceum Therapeutics. Ariceum Therapeutics has raised $48M in total funding. Latest round: Series A.
Manfred Rüdiger is the CEO of Ariceum Therapeutics, a clinical-stage radiopharmaceutical company focused on the targeted detection and treatment of hard-to-treat cancers. He has spoken about Ariceum's strategy following the company's Series A extension, UCB collaboration, and acquisition of Theragnostics.
Full founder directory · Investor directory · Company funding database · Fundraising library